Summary
This 8-K filing from CVS Health (CVS) details the voting results from its Annual Meeting of Stockholders held on May 9, 2013. The report confirms overwhelming support for management's proposals, including the election of all nine director nominees and the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2013. Additionally, shareholders approved the company's executive compensation (on a non-binding basis), an amendment to the Employee Stock Purchase Plan to add shares, and a change to the voting thresholds for the 'fair price provision' in the company's certificate of incorporation. Conversely, three shareholder proposals were rejected. These proposals focused on political contributions, accelerated equity award vesting upon a change in control, and lobbying reports. The significant majority of votes cast in favor of management-backed items and against shareholder-driven initiatives suggest a strong alignment between the company's strategy and its investor base at that time.
Key Highlights
- 1All 9 director nominees were overwhelmingly elected for one-year terms.
- 2Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year 2013 with strong shareholder approval.
- 3Shareholders approved, on a non-binding basis, the compensation of named executive officers.
- 4An amendment to the 2007 Employee Stock Purchase Plan to add shares was approved by a significant majority.
- 5A proposed amendment to the Certificate of Incorporation to adjust voting thresholds for the 'fair price provision' was also approved.
- 6Three shareholder proposals requesting reports on political contributions, accelerated executive equity vesting upon change of control, and lobbying were all rejected.